Copyright
©The Author(s) 2025.
World J Cardiol. Sep 26, 2025; 17(9): 110061
Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.110061
Published online Sep 26, 2025. doi: 10.4330/wjc.v17.i9.110061
Table 1 Characteristics of the selected studies
Ref. | Study design | Population characteristics | Sample size | Intervention (CCTA) | Comparator (stress testing) | Outcomes measured | Key findings | Follow-up duration |
Singh et al[11] | Post hoc of RCT | Adults aged 18-75 with suspected stable angina; Scotland clinics | 3283 | CCTA as add-on to standard care | Exercise ECG | CHD death, nonfatal MI, diagnostic accuracy | CCTA more predictive of CHD death/MI (HR 10.63); ECG: 39% sensitivity, 91% specificity | 5 years |
Stillman et al[12] | Multicenter RCT | Stable angina, intermediate risk; 44 sites | 1050 | CCTA to guide therapy/revascularization | SPECT MPI | MACE (MI, cardiac death), revascularization | Similar outcomes (HR 1.03); CCTA better predicted MACE; fewer events in CCTA-negative patients | Mean 16.2 months |
Lubbers et al[13] | Multicenter RCT | Stable angina; Dutch outpatient clinics | 350 | Tiered: CAC → CCTA | Functional (ECG, MPI, echo) | Event-free survival, symptoms, downstream testing, cost | Higher survival (96.7% vs 89.8%, P = 0.011); less downstream testing; lower cost | 1.2 years |
Lubbers et al[14] | Multicenter RCT | Stable angina; mean pretest CAD probability 54% | 268 | Tiered: CAC → CCTA → CT perfusion (if needed) | Functional (mostly exercise ECG) | Angiograms w/ and w/o revascularization, further testing, efficiency | Fewer unnecessary angiograms (1.5% vs 7.2%, P = 0.035); more revascularizations (88% vs 50%, P = 0.017) | 6 months |
Linde et al[15] | RCT | Acute chest pain with normal ECG/troponin | 600 | CCTA-guided; functional added if needed | Standard: Bicycle ECG or MPI | Composite: Death, MI, UAP, revascularization, readmission | Follow-up |
Table 2 Comparative outcomes between coronary computed tomography angiography and stress testing
Ref. | Sample Size | CCTA modality | Stress test comparator | Primary outcome(s) | Hazard ratio/statistics | Follow-up duration | Key findings |
Singh et al[11] | 3283 | CCTA as add-on to standard care | Exercise ECG | CHD death or nonfatal MI; diagnostic accuracy | HR for CHD death/MI: 10.63; ECG Sensitivity: 39%, Specificity: 91% | 5 years | CCTA strongly predicted CHD events; superior diagnostic accuracy over ECG |
Stillman et al[12] | 1050 (CCTA: 518; SPECT: 532) | CCTA to guide therapy and revascularization | SPECT MPI | MACE (MI or cardiac death); revascularization | HR 1.03 (NS); Event rate: 1.2% (CCTA-negative) vs 3.2% (SPECT-negative) | Mean 16.2 months | CCTA better identified patients at low risk and those needing revascularization |
Lubbers et al[13] | 350 | Tiered approach: CAC → CCTA | ECG, MPI, or Echo | Event-free survival; anginal symptoms; cost | Event-free survival: 96.7% (CCTA) vs 89.8% (Functional), P = 0.011 | 1.2 years | Higher event-free survival and cost-effectiveness in the CCTA group |
Lubbers et al[14] | 268 (CT: 130; Functional: 138) | CAC → CCTA → CT perfusion (if needed) | Mostly Exercise ECG | Angiograms (with/without revascularization); further testing | Unnecessary angiograms: 1.5% vs 7.2%, P = 0.035; Revascularization: 88% vs 50%, P = 0.017 | 6 months | CCTA reduced unnecessary procedures; improved selection for revascularization |
Linde et al[15] | 600 (CCTA: 299; Control: 301) | CCTA-guided strategy | Bicycle ECG or MPI | Composite: MI, cardiac death, UAP, revascularization, readmission | Composite events: 11% (CCTA) vs 16% (Control), HR 0.62, P = 0.04; MACE HR: 0.36 | Median 18.7 months | Control |
Table 3 Risk of bias assessment of included studies
Ref. | Randomization process | Deviations from intended interventions | Missing outcome data | Measurement of outcome | Selection of the reported result | Overall risk of bias |
Singh et al[11] | Low | Low | Low | Low | Low | Low |
Stillman et al[12] | Low | Low | Low | Low | Some concerns (limited outcome events may impact reporting) | Some concerns |
Lubbers et al[13] | Low | Low | Low | Low | Low | Low |
Lubbers et al[14] | Low | Low | Low | Low | Low | Low |
Linde et al[15] | Low | Low | Low | Low | Low | Low |
- Citation: Gundareddy V, Singla S, Mounika J, Owona O, Singla B, Singh T, Anwar S, Ramachandran V, Ullah H, Mazari S. Coronary computed tomography angiography vs stress testing for stable angina evaluation: Diagnostic and prognostic superiority. World J Cardiol 2025; 17(9): 110061
- URL: https://www.wjgnet.com/1949-8462/full/v17/i9/110061.htm
- DOI: https://dx.doi.org/10.4330/wjc.v17.i9.110061